MPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement Post author:GHIAA Admin Post published:March 7, 2023 Post category: Continue ReadingMPP – South African Medical Research Council, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement
MPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement Post author:GHIAA Admin Post published:March 6, 2023 Post category: Continue ReadingMPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement
BIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement Post author:GHIAA Admin Post published:March 3, 2023 Post category: Continue ReadingBIND Biosciences, Inc. – Yale University, Cancer Therapeutic, Exclusive License Agreement
National Health Service (NHS) – Pfizer/Shionogi, Antibiotic Supply Agreement Post author:GHIAA Admin Post published:March 2, 2023 Post category: Continue ReadingNational Health Service (NHS) – Pfizer/Shionogi, Antibiotic Supply Agreement
Drugs For Neglected Diseases Initiative – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement Post author:GHIAA Admin Post published:October 26, 2022 Post category: Continue ReadingDrugs For Neglected Diseases Initiative – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
Wellcome Trust – PTC Therapeutics, Cancer Treatment Research Funding Agreement Post author:GHIAA Admin Post published:October 25, 2022 Post category: Continue ReadingWellcome Trust – PTC Therapeutics, Cancer Treatment Research Funding Agreement
AXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement Post author:GHIAA Admin Post published:September 13, 2022 Post category: Continue ReadingAXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement
Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement Post author:GHIAA Admin Post published:September 6, 2022 Post category: Continue ReadingAlnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
Shionogi – GARDP, Cefiderocol License Agreement Post author:GHIAA Admin Post published:July 7, 2022 Post category: Continue ReadingShionogi – GARDP, Cefiderocol License Agreement